Safety, Pharmacokinetics, & Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-associated Hepatitis - Hassanein, Tarek; McClain, Craig J.; Vatsalya, Vatsalya; Stein, Lance L.; Flamm, Steven L; Martin, Paul; Cave, Matthew C.; Mitchell, Mack; Barton, Bruce; Nagy, Laura; Szabo, Gyongyi; McCullough, Arthur; et al. (The American journal of gastroenterology, 2024)
Keywords: Alcohol; Clinical trials; Consent; DNA methylation; Drug dosages; End Stage Liver Disease; Enrollments; Epigenetics; FDA approval; Hepatitis; Hepatitis, Alcoholic - diagnosis; Hepatitis, Alcoholic - drug therapy; Hospitalization; Hospitals; Human subjects; Humans; Infections; Liver; Liver diseases; Mortality; Pharmacokinetics; Pilot Projects; Severity of Illness Index; Toxicology; United States--US